Rx Only DESCRIPTION PHENOHYTRO ® ELIXIR Grape Flavored each 5 mL ( teaspoonful ) oral - administered dose of elixir contains : Phenobarbital , USP ( WARNING : may be habit forming ) 16 . 2 mg Hyoscyamine Sulfate , USP 0 . 1037 mg Atropine Sulfate , USP 0 . 0194 mg Scopolamine Hydrobromide , USP 0 . 0065 mg Alcohol not more than 23 . 8 % INACTIVE INGREDIENTS Purified water , glycerin , sorbitol , ethyl alcohol , sucrose , sodium saccharin , artificial grape flavor , FD & C Red No . 3 , FD & C Blue No . 1 .
DESCRIPTION PHENOHYTRO ® ELIXIR Mint Flavored each 5 mL ( teaspoonful ) oral - administered dose of elixir contains : Phenobarbital , USP ( WARNING : may be habit forming ) 16 . 2 mg Hyoscyamine Sulfate , USP 0 . 1037 mg Atropine Sulfate , USP 0 . 0194 mg Scopolamine Hydrobromide , USP 0 . 0065 mg Alcohol not more than 23 . 8 % INACTIVE INGREDIENTS Purified water , glycerin , sorbitol , ethyl alcohol , sucrose , sodium saccharin , artificial mint flavor , FD & C Yellow No . 5 , FD & C Blue No . 1 .
Phenobarbital is a barbiturate with the chemical name 2 , 4 , 6 ( 1 H , 3 H , 5 H ) - Pyrimidinetrione , 5 - ethyl - 5 - phenyl - .
It has the following structural formula : C12H12N2O3 [ MULTIMEDIA ] M . W . 232 . 2 Hyoscyamine sulfate is a belladonna alkaloid with the chemical name Benzeneacetic acid , α - ( hydroxmethyl ) - , 8 - methyl - 8 - azabicyclo [ 3 . 2 . 1 ] oct - 3 - yl ester , [ 3 ( S ) - endo ] - , sulfate ( 2 : 1 ) , dihydrate .
It has the following structural formula : [ MULTIMEDIA ] ( C17H23NO3 ) 2 ∙ H2SO4 ∙ 2H2O M . W . 712 . 85 Atropine sulfate is belladonna alkaloid with the chemical name : Benzeneacetic acid , α - ( Hydroxymethyl ) benzeneacetic acid 8 - methyl - 8 - azabicyclo [ 3 . 2 . 1 ] oct - 3 - yl ester .
It has the following structural formula : [ MULTIMEDIA ] ( C34H46N2O6 ∙ H2O4S ∙ H2O M . W . 694 . 83 Scopolamine hydrobromide is a belladonna alkaloid with the chemical name Benezeneacetic acid , α - ( hydroxymethyl ) - , 9 - methyl - 3 - oxa - 9 - azatricyclo [ 3 . 31 . 0 . 2 , 4 ] non - [ 7 - yl ester , hydrobromide , trihydrate , [ 7 ( S ) - ( 1α , 2β , 4β , 5α , 7β ) ] - .
It has the following structural formula : [ MULTIMEDIA ] C17H21NO4 ∙ BrH ∙ 3H2O M . W . 438 . 31 [ MULTIMEDIA ] [ MULTIMEDIA ] [ MULTIMEDIA ] [ MULTIMEDIA ] CLINICAL PHARMACOLOGY This drug combination provides phenobarbital combined with belladonna alkaloids in a specific , fixed ratio to provide anticholinergic / antispasmodic action and mild sedation .
Phenobarbital is a barbiturate , nonselective central nervous system depressant .
It is primarily used as a sedative hypnotic and also as an anticonvulsant in subhypnotic doses .
Atropine Sulfate , Hyoscyamine Sulfate , and Scopolamine are belladonna alkaloids classified as anticholinergic , antimuscarinic drugs .
They act to inhibit muscarinic actions of acetylcholine at postganglionic parasympathetic neuron effector sites .
These drugs are also used as antispasmodics due to their anticholinergic action .
They produce the effect in the body of reduced muscle spasms in the digestive or urinary tract , and reduced fluid secretions from certain glands or organs .
INDICATIONS AND USAGE Based on the National Academy of Sciences - National Research Council ' s review of this drug and / or other information , FDA has classified the following indications as " possibly " effective : For use as adjunctive therapy in the treatment of irritable bowel syndrome ( irritable colon , spastic colon , mucous colitis ) and acute enterocolitis .
May also be useful as adjunctive therapy in the treatment of duodenal ulcer .
IT HAS NOT BEEN SHOWN CONCLUSIVELY WHETHER ANTICHOLINERGIC / ANTISPASMODIC DRUGS AID IN THE HEALING OF A DUODENAL ULCER , DECREASE THE RATE OF RECURRENCES , OR PREVENT COMPLICATIONS .
CONTRAINDICATIONS PHENOHYTRO ® ELIXIR is contraindicated in patients with known hypersensitivity to any of the ingredients .
Phenobarbital is contraindicated in patients with acute intermittent porphyria and in those patients in which phenobarbital produces restlessness and / or excitement .
PHENOHYTRO ® ELIXIR is also contraindicated in patients with glaucoma , obstructive uropathy ; paralytic ileus ; myasthenia gravis ; intestinal atony ; unstable cardiovascular status in acute hemorrhage ; severe ulcerative colitis especially if complicated by toxic megacolon ; hiatal hernia associated with reflux esophagitis ; obstructive disease of the gastrointestinal tract ; or severe ulcerative colitis .
WARNINGS Heat prostration can occur with belladonna alkaloids in high temperatures .
Diarrhea may be an early symptom of incomplete intestinal obstruction , particularly in patients with ileostomy or colostomy .
In this instance , treatment with this drug could be harmful .
PHENOHYTRO ® ELIXIR may produce drowsiness and blurred vision .
The patient should be warned about engaging in hazardous work or activities requiring mental alertness , such as operating a motor vehicle or other machinery .
Phenobarbital may decrease the effect of anticoagulants , and larger doses of the anticoagulant may be necessary for optimal effect .
When phenobarbital is discontinued , the dose of the anticoagulant may have to be decreased .
Phenobarbital may be habit forming and should not be administered to patients who are susceptible to addiction or to those with a history of physical and / or psychological drug dependence .
Barbiturates should be used with caution in patients with hepatic dysfunction .
PRECAUTIONS GENERAL Use with caution in patients with : autonomic neuropathy , hepatic or renal disease , hyperthyroidism , coronary heart disease , congestive heart failure , cardiac arrhythmias , tachycardia , and hypertension .
Belladonna alkaloids may produce a delay in gastric emptying ( antral stasis ) , which would complicate the management of gastric ulcer .
Do not rely on the use of the drug in the presence of complication of biliary tract disease .
Theoretically , a curare - like action may occur with overdosage .
CARCINOGENESIS , MUTAGENESIS , IMPAIRMENT OF FERTILITY Long - term studies in animals have not been performed to evaluate carcinogenic potential .
PREGNANCY PREGNANCY CATEGORY C Animal reproduction studies have not been conducted with PHENOHYTRO ® ELIXIR .
It is not known whether PHENOHYTRO ® ELIXIR can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity .
PHENOHYTRO ® ELIXIR should be given to a pregnant woman only if clearly needed .
NURSING MOTHERS It is not known whether this drug is excreted in human milk .
Because many drugs are excreted in human milk , exercise caution when administering PHENOHYTRO ® ELIXIR to a nursing woman .
INFORMATION FOR PATIENTS Practitioners should give the following information and instructions to patients : • Do not increase the dose of this drug without consulting a physician .
• Do not share this medication with others .
• The use of this product carries with it an associated risk of psychological and / or physical dependence .
• The use of this product may impair mental and / or physical abilities required for the performance of potentially hazardous tasks such as driving or operating machinery .
• Use of this product with alcohol may result in additional central nervous system depressant effects .
• Tell your doctor or pharmacist if you also take antihistamines , anti - seizure drugs , medicine for sleep or anxiety , muscle relaxants , narcotic pain relievers , or psychiatric medicines .
• This drug may increase the risk for heatstroke because it decreases sweating .
Avoid becoming overheated in hot weather , saunas , and during exercise or other strenuous activity .
ADVERSE REACTIONS Call your doctor for medical advice about side effects .
Adverse reactions associated with anticholinergics and / or anticonvulsants are : dry mouth ; tachycardia ; urinary hesitancy and retention ; palpitation ; blurred vision ; prolonged pupil dilation ; cycloplegia ; increased ocular tension ; loss of taste sense ; headache ; nervousness ; drowsiness ; weakness ; dizziness ; insomnia ; nausea ; vomiting ; severe allergic reaction or drug idiosyncrasies , including anaphylaxis , hives and / or other dermal manifestations ; decreased sweating ; impotence ; suppression of lactation ; constipation ; bloated feeling and musculoskeletal pain .
Elderly patients may react with symptoms of excitement , agitation and drowsiness to even small doses of the drug .
Phenobarbital may produce excitement in some patients , rather than a sedative effect .
In patients habituated to barbiturates , abrupt withdrawal may produce delirium or convulsions .
To report SUSPECTED ADVERSE REACTIONS , contact Winder Laboratories , LLC at 1 - 770 - 307 - 0702 , or FDA at 1 - 800 - FDA - 1088 or www . fda . gov / medwatch .
OVERDOSAGE The signs and symptoms of overdose are headache , nausea , vomiting , blurred vision , dilated pupils , hot and dry skin , dizziness , dryness of the mouth , difficulty in swallowing , and CNS stimulation .
Call your doctor or local Poison Control Center if overdosage is suspected .
The dosage of PHENOHYTRO ® ELIXIR should be adjusted to the needs of the individual patient to assure symptomatic control with a minimum of adverse effects .
DOSAGE AND ADMINISTRATION Adults One or two teaspoonfuls of PHENOHYTRO ® ELIXIR three or four times a day according to conditions and severity of symptoms .
Pediatric patients may be dosed every 4 to 6 hours .
Starting DosageBody Weight q4h q6h 10 lb .
( 4 . 5 kg ) 0 . 5 mL 0 . 75 mL 20 lb .
( 9 . 1 kg ) 1 . 0 mL 1 . 5 mL 30 lb .
( 13 . 6 kg ) 1 . 5 mL 2 . 0 mL 50 lb .
( 22 . 7 kg ) 1 / 2 tsp 3 / 4 tsp 75 lb .
( 34 kg ) 3 / 4 tsp 1 tsp 100 lb .
( 45 . 4 kg ) 1 tsp 1 1 / 2 tsp HOW SUPPLIED PHENOHYTRO ® ELIXIR Grape Flavored is a purple colored , grape flavored liquid .
NDC 75826 - 127 - 04 Grape Flavored in 4 oz bottles .
NDC 75826 - 127 - 16 Grape Flavored in 16 oz bottles .
PHENOHYTRO ® ELIXIR Mint Flavored is a green colored , mint flavored liquid .
NDC 75826 - 128 - 04 Mint Flavored in 4 oz bottles .
NDC 75826 - 128 - 16 Mint Flavored in 16 oz bottles .
STORAGE CONDITIONS AVOID FREEZING Store PHENOHYTRO ® ELIXIR at 20 ° - 25 ° C ( 68 ° - 77 ° F ) [ see USP Controlled Room Temperature ] .
Protect from light and moisture .
Dispense in a tight , light - resistant container as defined in the USP using a child - resistant closure .
Use safety closures when dispensing this product unless otherwise directed by a physician or requested by purchaser .
WARNINGS : KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN .
IN THE CASE OF OVERDOSE , SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY .
Contains color additives , including FD & C Yellow No . 5 ( tartrazine ) .
Manufactured by : Winder Laboratories , LLC .
Winder , GA 30680 70102US10 Rev . 05 / 18 PRINCIPAL DISPLAY PANEL - 16 fl .
oz .
Bottle Label - Mint NDC 75826 - 128 - 16 winder ® LABS Phenohytro ® Elixir Mint Flavored Each 5 mL ( 1 teaspoonful ) contains : Phenobarbital , USP 16 . 2 mg Hyoscyamine Sulfate , USP 0 . 1037 mg Atropine Sulfate , USP 0 . 0194 mg Scopolamine Hydrobromide , USP 0 . 0065 mg Alcohol not more than 23 . 8 % DO NOT USE IF TAMPER - EVIDENT SEAL UNDER CAP IS BROKEN OR MISSING Rx Only 16 fl .
oz .
[ MULTIMEDIA ] [ MULTIMEDIA ] PRINCIPAL DISPLAY PANEL - 16 fl .
oz .
Bottle Label - Grape NDC 75826 - 127 - 16 winder ® LABS Phenohytro ® Elixir Grape Flavored Each 5 mL ( 1 teaspoonful ) contains : Phenobarbital , USP 16 . 2 mg Hyoscyamine Sulfate , USP 0 . 1037 mg Atropine Sulfate , USP 0 . 0194 mg Scopolamine Hydrobromide , USP 0 . 0065 mg Alcohol not more than 23 . 8 % DO NOT USE IF TAMPER - EVIDENT SEAL UNDER CAP IS BROKEN OR MISSING Rx Only 16 fl .
oz .
[ MULTIMEDIA ] [ MULTIMEDIA ]
